MétaCan
← all works

Cellular senescence and its effector programs

2014· review· en· 843 citations· W1973300568 on OpenAlex· 10.1101/gad.235184.113

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.

No Canadian affiliation. An affiliation-only frame — the usual design — would never have seen this work. It is one of the works that make the case for inverting the frame.

Abstract

Cellular senescence is a stress response that accompanies stable exit from the cell cycle. Classically, senescence, particularly in human cells, involves the p53 and p16/Rb pathways, and often both of these tumor suppressor pathways need to be abrogated to bypass senescence. In parallel, a number of effector mechanisms of senescence have been identified and characterized. These studies suggest that senescence is a collective phenotype of these multiple effectors, and their intensity and combination can be different depending on triggers and cell types, conferring a complex and diverse nature to senescence. Series of studies on senescence-associated secretory phenotype (SASP) in particular have revealed various layers of functionality of senescent cells in vivo. Here we discuss some key features of senescence effectors and attempt to functionally link them when it is possible.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

The record

Venue
Genes & Development
Topic
Telomeres, Telomerase, and Senescence
Field
Medicine
Canadian institutions
Funders
Canadian Institutes of Health ResearchUniversity of CambridgeCancer Research UK
Keywords
SenescenceEffectorBiologyPhenotypeCell biologySuppressorCellular senescenceCellGeneticsGene
Has abstract in OpenAlex
yes